Post
Strategies and innovations for reducing drug product loss in sterile filling
Sterile filling is a critical step in pharmaceutical primary packaging; the transfer of sterile drug product into its final primary …
Seagen reports positive data on Tukysa from Phase III breast cancer trial
Seagen has reported positive topline data from the Phase III HER2CLIMB-02 clinical trial investigating Tukysa (tucatinib) in combination with the …
Geron completes 50% subject enrolment in Phase III myelofibrosis trial
Geron has completed 50% subject enrolment in the Phase III IMpactMF clinical trial of its telomerase inhibitor, imetelstat, to treat …
Syros reports initial findings from acute myeloid leukaemia trial
Syros Pharmaceuticals has reported encouraging initial findings from its SELECT-AML-1 Phase II clinical trial of tamibarotene plus venetoclax and azacitidine …
Q&A: Dr Christina Yap talks about SPIRIT and CONSORT guidance
The CONSORT2010 guidance is used globally when academics are writing papers on clinical trials, providing a checklist for researchers to …
Q&A: Dr Christina Yap talks about SPIRIT and CONSORT guidance
The CONSORT2010 guidance is used globally when academics are writing papers on clinical trials, providing a checklist for researchers to …
Delpor on track with schizophrenia implant late-stage trials
Delpor is sketching out late-stage clinical trial plans for its drug-device combination implant DLP-114 (risperidone) in schizophrenia. After presenting topline results …
Anixa and Cleveland Clinic report Phase I breast cancer vaccine data
Anixa Biosciences and Cleveland Clinic in the US have reported positive data from the Phase I clinical trial of breast …
MyMD to begin Phase II trial of rheumatoid arthritis therapy
MyMD Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA) for its investigational new drug (IND) application …
Signal: FDA renews Syapse collaboration to use real-world data in oncology
The US Food and Drug Administration (FDA) has renewed a four-year collaboration agreement between its Oncology Center of Excellence and …
Velocity Clinical Research pushes further into Europe with new Polish site
Clinical trial site organisation Velocity Clinical Research has announced that it has expanded into Poland, establishing a new site with …
Exploring prevalence patterns of CD and UC in the US, Canada, 5EU, and Japan
Crohn’s disease (CD) and ulcerative colitis (UC) are two forms of inflammatory bowel disease (IBD) that affect millions of people …
Merck partners with HiberCell for Phase Ib renal carcinoma trial
Merck & Co (MSD) and HiberCell have partnered to conduct a Phase Ib trial to evaluate the combination therapy of …
Gilgamesh to initiate Phase IIa trial of fast-acting psychedelic drug
US-based Gilgamesh Pharmaceuticals will initiate its Phase IIa trial investigating GM-2505, a novel 5-HT2A receptor agonist, in Q1 2024, chief …
NeuroSense’s trial of ALS drug meets primary and secondary endpoints
NeuroSense Therapeutics has reported that the Phase IIb PARADIGM clinical trial of its drug candidate, PrimeC, in amyotrophic lateral sclerosis …